Pyridazine derivatives useful as cannabinoid - 2 agonists

Details for Australian Patent Application No. 2011213621 (hide)

Owner Allergan, Inc.

Inventors Chen, June; Pettit, Simon N.; Fliri, Hans G.

Agent Davies Collison Cave

Pub. Number AU-A-2011213621

PCT Pub. Number WO2011/097553

Priority 61/302,384 08.02.10 US

Filing date 7 February 2011

Wipo publication date 11 August 2011

International Classifications

C07D 237/22 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

A61K 31/50 - Pyridazines

A61K 31/5025 - ortho- or peri-condensed with heterocyclic ring systems

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/097553 Priority application(s): WO2011/097553

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011213623-Sunscreen compositions comprising an ultraviolet radiation-absorbing polymer

2011213620-Fraud reduction system for transactions